Microbot Medical Inc.
MBOTNasdaqCIK 883975HealthcareFiscal year ends Dec 31
Reports and events: 543 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2308:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048182 |
| 2026-10-2008:30 ET | 8-K | 5.08 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-047702 |
| 2026-10-0608:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-045866 |
| 2026-09-2806:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-044429 |
| 2026-08-1110:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037031 |
| 2026-08-1109:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037009 |
| 2026-08-0716:30 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-036600 |
| 2026-07-2108:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034014 |
| 2026-07-0708:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-032260 |
| 2026-06-3008:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-031205 |
| 2026-06-2508:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030038 |
| 2026-06-2308:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-029709 |
| 2026-06-1608:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028824 |
| 2026-06-0908:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-027861 |
| 2026-06-0208:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-026769 |
| 2026-05-2608:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-025171 |
| 2026-05-1512:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-023493 |
| 2026-05-1408:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-022886 |
| 2026-05-1317:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022792 |
| 2026-05-0508:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-021231 |
| 2026-04-3008:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-019775 |
| 2026-04-2208:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018453 |
| 2026-04-1408:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-016484 |
| 2026-04-1308:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016293 |
| 2026-04-1017:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016198 |
| 2026-03-2616:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-012935 |
| 2026-03-2608:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-012812 |
| 2026-03-2408:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-012281 |
| 2026-03-1709:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-010446 |
| 2026-03-1008:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009454 |
| 2026-03-0408:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008782 |
| 2026-03-0309:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008658 |
| 2026-02-2417:00 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-007900 |
| 2026-02-2408:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-007827 |
| 2026-02-1908:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-007429 |
| 2026-02-1208:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006310 |
| 2026-02-0508:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005206 |
| 2026-01-1208:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-001234 |
| 2025-11-2608:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-025069 |
| 2025-11-1216:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021929 |
| 2025-11-0508:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-020815 |
| 2025-10-1608:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-018260 |
| 2025-10-1408:42 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017941 |
| 2025-10-0708:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017212 |
| 2025-10-0316:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-016866 |
| 2025-10-0109:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-016484 |
| 2025-09-2308:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-014557 |
| 2025-09-1916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-014263 |
| 2025-09-1617:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013743 |
| 2025-09-0909:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-026942 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:31 ET. Listed shows no prices and gives no investment advice.